Search - tctmd.com

Displaying 21 - 40 of 46

Sort: Relevancy | Date

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

Presentation TCT 2019

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

Tackling Inflammation: Novel Targets

Presenter: Wolfgang Koenig

September 26, 2019

Presentation TCT 2019

LP(a): Not So Little Anymore

Presenter: Roberta Rossini

September 26, 2019

Presentation TCT 2019

Don’t Forget About Your HDL: The AEGIS Program

Presenter: C. Michael Gibson

September 26, 2019

Presentation TCT 2019

Role of PCSK9 Inhibitors Post-PCI and ACS

Presenter: Marc Bonaca

September 26, 2019

Presentation TCT 2019

Loading Dose Statin Prior PCI: Is There a Role For It?

Presenter: Renato Lopes

September 26, 2019

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

Presentation TCT 2018

TCT-56: High-Resolution Intravascular OCT-NIRF Molecular Imaging for In Vivo Assessment of Inflammation in Atherosclerosis and Vascular Injury

Presenter: John A. Ambrose, Farouc A Jaffer, Zhonglie Piao

September 21, 2018

Presentation TCT 2016

YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy

Presenter: Spencer B. King III, Jagat Narula, Annapoorna Kini

October 31, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

News Conference News TCT 2014

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

September 19, 2014

Presentation TCT 2014

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Presenter: Kazuyuki Yahagi

September 16, 2014

News Conference News TCT 2014

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

September 16, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

The effect of inflammation on left ventricular function after trancatheter aortic valve implantation

Presenter: Manolis Vavuranakis, Maria Kariori, Konstantinos Kalogeras, Dimitrios Vrachatis, Carmen Moldovan, Konstantinos Aznaouridis, Evangelia Gravia, Christodoulos Stefanadis

January 31, 2013

Advertisement

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

Novel Approaches in Diabetic Patients After PCI: Role of SGLT2 Inhibitors and Potent Antiplatelet Therapy (THEMIS)

Tackling Inflammation: Novel Targets

LP(a): Not So Little Anymore

Don’t Forget About Your HDL: The AEGIS Program

Role of PCSK9 Inhibitors Post-PCI and ACS

Loading Dose Statin Prior PCI: Is There a Role For It?

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

TCT-56: High-Resolution Intravascular OCT-NIRF Molecular Imaging for In Vivo Assessment of Inflammation in Atherosclerosis and Vascular Injury

YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

Comparison of endothelialization and inflammation between thin- and thick-strut contemporary bioerodable polymer drug-eluting stents and thick-strut fully resorbable scaffolds i___

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

Keynote Address Focuses on Newer DES, Problematic Subgroups

ABSORB III and IV Trials Aim to Prove Superiority of BVS

The effect of inflammation on left ventricular function after trancatheter aortic valve implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content